[HTML][HTML] A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses
M Cao, J Cai, Y Yuan, Y Shi, H Wu, Q Liu… - Cancer Biology & …, 2019 - ncbi.nlm.nih.gov
Objective Glioblastoma (GBM) is the most common primary malignant brain tumor regulated
by numerous genes, with poor survival outcomes and unsatisfactory response to therapy …
by numerous genes, with poor survival outcomes and unsatisfactory response to therapy …
[HTML][HTML] A 6-gene risk signature predicts survival of glioblastoma multiforme
J Zhao, L Wang, G Hu, B Wei - Biomed Research International, 2019 - hindawi.com
Background. This study aims to develop novel signatures for glioblastoma multiforme (GBM).
Methods. GBM expression profiles from The Cancer Genome Atlas (TCGA) were …
Methods. GBM expression profiles from The Cancer Genome Atlas (TCGA) were …
[HTML][HTML] Comprehensive development and validation of gene signature for predicting survival in patients with glioblastoma
Y Jin, Z Wang, K Xiang, Y Zhu, Y Cheng, K Cao… - Frontiers in …, 2022 - frontiersin.org
Glioblastoma (GBM) is the most common brain tumor, with rapid proliferation and fatal
invasiveness. Large-scale genetic and epigenetic profiling studies have identified targets …
invasiveness. Large-scale genetic and epigenetic profiling studies have identified targets …
[HTML][HTML] Identification of a Novel Eight-Gene Risk Model for Predicting Survival in Glioblastoma: A Comprehensive Bioinformatic Analysis
Simple Summary People with glioblastoma (GBM) universally have poor survival despite
undergoing aggressive treatments. In this study, we aimed to determine genetic biomarkers …
undergoing aggressive treatments. In this study, we aimed to determine genetic biomarkers …
[HTML][HTML] Expression profile analysis identifies a novel five-gene signature to improve prognosis prediction of glioblastoma
W Yin, G Tang, Q Zhou, Y Cao, H Li, X Fu, Z Wu… - Frontiers in …, 2019 - frontiersin.org
Glioblastoma multiforme (GBM) is the most aggressive primary central nervous system
malignant tumor. The median survival of GBM patients is 12–15 months, and the 5 years …
malignant tumor. The median survival of GBM patients is 12–15 months, and the 5 years …
A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing
Purpose Glioblastoma (GBM) is the most common and deadly brain tumor. We aimed to
reveal potential prognostic GBM marker genes, elaborate their functions, and build an …
reveal potential prognostic GBM marker genes, elaborate their functions, and build an …
[HTML][HTML] Identification of a specific gene module for predicting prognosis in glioblastoma patients
X Tang, P Xu, B Wang, J Luo, R Fu, K Huang… - Frontiers in …, 2019 - frontiersin.org
Introduction: Glioblastoma (GBM) is the most common and malignant variant of intrinsic glial
brain tumors. The poor prognosis of GBM has not significantly improved despite the …
brain tumors. The poor prognosis of GBM has not significantly improved despite the …
[HTML][HTML] Angiogenesis-related gene signature-derived risk score for glioblastoma: Prospects for predicting prognosis and immune heterogeneity in glioblastoma
G Wang, JQ Hu, JY Liu, XM Zhang - Frontiers in Cell and …, 2022 - frontiersin.org
Background: Glioblastoma multiforme (GBM) is the most common malignant tumor in the
central nervous system with poor prognosis and unsatisfactory therapeutic efficacy …
central nervous system with poor prognosis and unsatisfactory therapeutic efficacy …
[HTML][HTML] Large-scale analysis reveals gene signature for survival prediction in primary glioblastoma
Glioblastoma multiforme (GBM) is the most aggressive and common primary central nervous
system tumour. Despite extensive therapy, GBM patients usually have poor prognosis with a …
system tumour. Despite extensive therapy, GBM patients usually have poor prognosis with a …
A 4‐gene panel predicting the survival of patients with glioblastoma
XX Guo, J Su, XF He - Journal of cellular biochemistry, 2019 - Wiley Online Library
Background To identify independently prognostic gene panel in patients with glioblastoma
(GBM). Materials and methods The Cancer Genome Atlas (TCGA)‐GBM was used as a …
(GBM). Materials and methods The Cancer Genome Atlas (TCGA)‐GBM was used as a …